Press Releases
Biopharmaceutical Contract Manufacturing Market Latest Report with Forecast to 2025

, 13 March 2018 -- Biopharmaceutical Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Contract manufacturing organizations (CMOs) are companies that offer a broad spectrum of services ranging from drug development to drug manufacturing on contract basis to the pharmaceutical companies. Biopharmaceutical contract manufacturing involves the development and manufacture of biopharmaceutical molecules for biopharmaceutical companies. Biopharmaceuticals include pharmaceutical products such as proteins, nucleic acids, blood components, and vaccines developed from biological sources.

The biopharmaceutical contract manufacturing market is anticipated to expand robustly during the forecast period. Strong growth of the market can be attributed to the risk hedging nature of biopharmaceutical companies by outsourcing manufacturing to CMOs. This enables biopharmaceutical companies to balance their risk and buy time until key clinical trial milestones are met. Additionally, lack of manufacturing capabilities and high investments required in R&D of biopharmaceuticals induce new market entrants to outsource manufacturing activities.

Download Report Brochure @

Moreover, strong technical capabilities of the CMOs in cell-line development, scale-up, and process development, and rich pipeline of biologics such as viral vectors, multispecific monoclonal antibodies, peptides, and other oligonucleotides drive the biopharmaceutical contract manufacturing market. However, lack of capacity of CMOs to manufacture large-volume biopharmaceutical drug substances, complexity in transferring biological components, and limited options available for biopharmaceutical companies for large-volume production are projected to hamper the growth of the market.

The global biopharmaceutical contract manufacturing market can be segmented based on product type, platform, application, therapeutic area, services, and region. In terms of product type, the market can be classified into interferons, monoclonal antibodies, vaccines, recombinant hormones, growth factors, and others. Based on platform, the global biopharmaceutical contract manufacturing market can be categorized into mammalian and microbial. In terms of application, the market can be bifurcated into commercial and clinical.

Based on therapeutic area, the global biopharmaceutical contract manufacturing market can be segmented into oncology, cardiovascular diseases, metabolic disorders, neurology, respiratory diseases, hematology, autoimmune diseases, and others. In terms of services, the market can be bifurcated into manufacturing and research. The manufacturing services segment can be further divided into bulk drugs and active pharmaceutical ingredient (API) manufacturing, packaging, advanced drug delivery formulations, and finished dose formulations.

Request for TOC @

Geographically, the global biopharmaceutical contract manufacturing market can be segmented into five regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for the largest share of the global biopharmaceutical contract manufacturing market in terms of revenue in 2016. The trend is anticipated to continue during the forecast period. However, the market in Asia Pacific is anticipated to expand at a significant pace during the forecast period. Rise in investments by contract manufacturing organizations in the region, increase in the number of companies outsourcing manufacturing activities to CMOs, and business and regulatory reforms contribute to the growth of the market.

For instance, in August 2017, Fujifilm Holdings announced expansion of its biopharmaceutical contract manufacturer business by doubling the capacity of culture tanks by 2019. Growth of the market in Asia Pacific is anticipated to be driven by India and China. Focus on the development of biologics pipelines by domestic companies in China and rise in adoption of newer technology platforms such as single-use technologies by CMOs have been contributing to the growth of the market in the country.

Leading players operating in the global biopharmaceutical contract manufacturing market are Lonza Group, Samsung Biologics Co., Ltd., Rentschler Biotechnologie GmbH, Catalent, Inc., Fujifilm Diosynth Biotechnologies, Patheon N.V., Abzena plc, Ajinomoto Althea, Inc., Vetter Pharma International GmbH, WuXi Biologics, Boehringer Ingelheim GmbH, Pfizer CentreOne (contract manufacturing unit of Pfizer, Inc.,), and Cytovance Biologics, Inc., among others.

Enquiry for discount on this report @

# # #

Submitted by Sandy Researcher, Transparency Market Research on Tuesday, 13 March 2018 at 6:19 PM
Category: Health Care & Medical
Related News

Radiation Dose Management Market to Register CAGR of Over 9.0% from 2017 to 2025
Tuesday, 20 Mar 2018

Breast Imaging Equipment Market Segmentation Detailed Study with Forecast to 2025
Tuesday, 20 Mar 2018

Joint Reconstruction Device Market Review with Forecast Research Report 2017 - 2025
Tuesday, 20 Mar 2018

Venturi Mask Market Latest Report with Forecast to 2025
Tuesday, 20 Mar 2018

Delirium Market by Application, Trends and Growth Rate to 2019
Tuesday, 20 Mar 2018

Related Events

Imaging in Hawaii
Monday, 19 Mar 2018

9th Proactive GCP Compliance
Monday, 19 Mar 2018

The International ADHD Congress (ADHD 2018)
Monday, 19 Mar 2018

ICI Boston Summit
Monday, 19 Mar 2018

ISPE 2018 Europe Annual Conference
Monday, 19 Mar 2018

Latest News

Transporting Seniors Is Made Easier And Professional By Care Conextion
Wednesday, 21 Mar 2018

Kugali Anthology Project On Kickstarter Generates Global Interest On African Tales
Wednesday, 21 Mar 2018

Product sampling New York to establish trust
Wednesday, 21 Mar 2018

Radiation Dose Management Market to Register CAGR of Over 9.0% from 2017 to 2025
Tuesday, 20 Mar 2018

Kugali Anthology Kickstarter Project Wins Remarkable Feedback From Contributors
Tuesday, 20 Mar 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 21 March 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Argus California Carbon and LCFS Summit
  • Imaging in Hawaii
  • 9th Proactive GCP Compliance
  • The International ADHD Congress (ADHD 2018)
  • ICI Boston Summit

  • Latest Jobs
    Sorry, there are currently no entries posted here.